From the UK: Adverse Association Identified for Calcium Channel Blocker Use, Glaucoma
From the UK: Adverse Association Identified for Calcium Channel Blocker Use, Glaucoma
There is an adverse association between calcium channel blocker (CCB) use and glaucoma, according to a study published online Sept. 7 in JAMA Ophthalmology.
Alan Kastner, M.D., from Moorfields Eye Hospital National Health Service Foundation Trust and University College London, and colleagues examined the association between systemic CCB use and glaucoma and related traits in a population-based cross-sectional study involving U.K. Biobank participants with complete data for analysis of glaucoma status, intraocular pressure (IOP), and optical coherence tomography-derived inner retinal layer thicknesses. Data were included for 427,480 adults (median age, 58 years), including 33,175 CCB users (7.8 percent).
Source: Advances and More licensed by HealthDay
https://advancesandmore.com/advances_article.htm?id=2664999068&client=BEE80FAF§ion=undefined
